Number of Shares
136,605.00
Current Holdings Value*
$3.74 Mil
% of Portfolio
2.05%
Total Estimate Gain
$1.25 Mil
% of Total Estimate Gain
14.69%

Checkpoint Capital L.P.'s Kymera Therapeutics Inc Holding Summary

As of 2025-03-31, Checkpoint Capital L.P. held 136,605.00 shares of Kymera Therapeutics Inc(KYMR), totaling $3.74 Mil. This investment constitutes 2.05% of their stock portfolio, and Checkpoint Capital L.P. now holds 0.21% of the outstanding Kymera Therapeutics Inc(KYMR) stock.

The initial trade took place in 2024Q2. And since then Checkpoint Capital L.P. has made 3 purchases of KYMR, at an average price of $38.85, for a total of 218,605.00 shares. In addition, there have been 1 sales at an average price of $44.16 for 82,000.00 shares. Based on historical transaction data and KYMR's current price of $44.79, Checkpoint Capital L.P.'s estimated gain on his KYMR holdings is $1.25 Mil, reflecting a 14.69% gain to date.

Checkpoint Capital L.P. KYMR ($44.79) Holding Chart

Checkpoint Capital L.P. KYMR ($44.79) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1